Overall, HNSCC samples exhibited a predominantly low immune-active status [low immune active: 79% (74/94) vs. high immune active: 21% (20/94)], suggesting T cell exhaustion, particularly of CD8+ T cells, and potential sensitivity to ICI therapy. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.